NCT06539221View on ClinicalTrials.gov

Sphingolipids in Asthma Pathogenesis

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2026

Conditions

Asthma

Trial Locations (1)

100191

Peking university third hospital, Beijing

All Listed Sponsors

lead

Peking University Third Hospital

OTHER